COMPUTEX
4.6.2021 12:05:06 CEST | Business Wire | Press release
The second day of COMPUTEX Forum, organized by TAITRA, featured "Critical Technology" and "Tomorrow Tech." World-renown tech leaders such as Qualcomm, QCT, WIN Semiconductors Corp., Siemens, Far EasTone Telecom, NVIDIA, and IBM shared their perspectives on the latest development of 5G, AI & IoT, and quantum computing, as well as their strategies for navigating in the new normal.
Cynthia Kiang, Director General of the Bureau of Foreign Trade, MOEA, Taiwan, said in her opening remarks that the recent global chip shortage underscores the importance of supply chain resilience, and that international cooperation is the best way to ensure supply chain efficiency and stability. She expects COMPUTEX to be a platform that helps with integrating global resources, allowing ecosystem partners to explore future business opportunities.
Qualcomm: Empowering the future of PC with mobile computing
With the onset of the pandemic and shift to remote working and learning, the way people use PCs has rapidly expanded. Alex Katouzian, Senior Vice President and General Manager of Mobile, Compute, and Infrastructure for Qualcomm Technologies, shared his unique perspectives on how 5G along with always connected PC are facilitating connectivity, mobility, and productivity as PC becomes the best collaborative tool in a mobile office. Qualcomm will also continue to collaborate with its ecosystem partners to realize the future of always connected PC.
QCT: 5G New Era: Great Convergence, Broad Ecosystem, Golden Opportunity
Mike Yang, President of QCT, talks about the great convergence of IT and CT, and the many new entrants into the Telco ecosystem that are changing our daily lives. With them more and more service providers will push for digital transformation and build 5G networks that will open up new opportunities for everyone, including operators and enterprises.
WIN Semiconductors Corp: Shaping the future with compound semiconductors
Dr. Yu-Chi (YC) Wang, Vice Chairman of WIN Semiconductors Corp emphasized that compound semiconductors are essential in realizing a life style built on seamless connection, precise sensing, and efficiency power. In addition, future life will be based on ubiquitous AI access with 6G, super IoT, and AI. Compound semiconductor will play a pivotal role to advance that future.
Siemens: Industrial 5G, Grid Edge and Connected Mobility will accelerate smart economy development and drive industrial innovation and transformation
Taiwan is crucial in the global supply chain of ICT components with a comprehensive industrial value chain. Erdal Elver, President and CEO of Siemens Taiwan pointed out that Taiwan has a clear advantage in introducing 5G innovative applications in manufacturing and city infrastructure. Siemens’ world-leading technologies and success stories in Industrial 5G, Grid Edge and Connected Mobility will assist Taiwan in ushering in application innovation in a variety of fields, helping Taiwan move toward its vision of "Digital Nation, Smart Island."
Far EasTone Telecom: Enabling clinical intelligence through telemedicine with 5G, IoT, big data, and AI
Chee Ching, President of Far EasTone Telecom, discussed medical applications in the 5G era. Telemedicine supported by 5G is capable of diagnosing patients remotely through features such as high resolution, big bandwidth, low latency, and massive connectivity. Telemedicine will also be able to detect and prevent diseases using big data and AIoT, ushering a new era of smart medicine. Chee Ching also pointed out that long-term care will be the extended application field for telehealth. With Taiwan expected to become a super-aged society by 2026, Far EasTone Telecom views this not only as a business opportunity but also as a social responsibility.
NVIDIA: Empowering collaboration across shared virtual worlds by addressing 3D workflows
Richard Kerris, NVIDIA Head of Worldwide Developer Relations and General Manager of Omniverse, indicated that a distributed workforce has become the norm with the rise of hybrid work. Remote working, however, has deepened the challenges of 3D workflows. NVIDIA Omniverse, the revolutionary new platform for virtual collaboration and simulation, can empower individuals and companies across multiple industries to address the challenges of complex 3D workflows by connecting users, content creation tools, and enabling AI to be used across shared virtual worlds.
IBM: Quantum computing
Norishige Morimoto, Vice President of IBM Research and Development of Japan, stated that quantum computing has yet to overcome obstacles on hardware and application development before becoming available for all. Now, IBM is collaborating with industry and universities including NTU, focusing on finance, chemistry, material industries.
2021 COMPUTEX Forum and keynote speeches are all available for viewing on #COMPUTEXVirtual online platform and COMPUTEX YouTube channel from now.
For more information:
COMPUTEX : https://www.computextaipei.com.tw/
InnoVEX : https://www.innovex.com.tw/
About COMPUTEX
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About COMPUTEX 2021 Virtual
As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX,Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnovexVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.
Explore #COMPUTEXVirtual now at https://virtual.computextaipei.com.tw/ .
About TAITRA
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210604005260/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom